SAR441566 Clinical Trials (2026): 7 Studies for Rheumatoid Arthritis & Psoriasis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
7 SAR441566 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 4 indications (including Rheumatoid Arthritis & Psoriasis) and 1,057 total planned enrollment. 2 SAR441566 clinical trials are actively recruiting at 38 U.S. sites across 14 states. Most recent activity: NCT06637631 (May 2029).
Where to Participate: All SAR441566 Trial Sites in the U.S. (38 sites across 14 states)
Every actively recruiting SAR441566trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400003 | Sun City85351 | NCT06867094 | Map |
| AZ | GI Alliance - Arizona Digestive Health - Sun City- Site Number : 8400020 | Sun City85351 | NCT06637631 | Map |
| CT | Bristol Hospital- Site Number : 8400007 | Bristol06010 | NCT06637631 | Map |
| CT | Bristol Hospital- Site Number : 8400017 | Bristol06010 | NCT06867094 | Map |
| FL | Novum Research- Site Number : 8400018 | Clermont34711 | NCT06867094 | Map |
| FL | Novum Research- Site Number : 8400021 | Clermont34711 | NCT06637631 | Map |
| FL | Homestead Associates in Research- Site Number : 8400012 | Homestead33033 | NCT06637631 | Map |
| FL | Clinical Research of Osceola- Site Number : 8400012 | Kissimmee34741 | NCT06867094 | Map |
| FL | Clinical Research of Osceola- Site Number : 8400013 | Kissimmee34741 | NCT06637631 | Map |
| FL | Wellness Clinical Research - Miami Lakes - 8181 Northwest 154th Street- Site Number : 8400002 | Miami Lakes33016 | NCT06867094 | Map |
| FL | Wellness Clinical Research - Miami Lakes - 8181 Northwest 154th Street- Site Number : 8400010 | Miami Lakes33016 | NCT06637631 | Map |
| FL | GCP Clinical Research- Site Number : 8400004 | Tampa33609 | NCT06637631 | Map |
| FL | GCP Clinical Research- Site Number : 8400016 | Tampa33609 | NCT06867094 | Map |
| IL | GI Alliance - Glenview- Site Number : 8400005 | Glenview60026 | NCT06867094 | Map |
| IL | GI Alliance - Glenview- Site Number : 8400015 | Glenview60026 | NCT06637631 | Map |
| IL | Illinois Gastroenterology Group- Site Number : 8400004 | Gurnee60031 | NCT06867094 | Map |
| IL | Illinois Gastroenterology Group- Site Number : 8400011 | Gurnee60031 | NCT06637631 | Map |
| MI | University of Michigan Health System - Ann Arbor- Site Number : 8400010 | Ann Arbor48109 | NCT06867094 | Map |
| MI | University of Michigan Health System - Ann Arbor- Site Number : 8400017 | Ann Arbor48109 | NCT06637631 | Map |
| MS | Gi Alliance - Flowood- Site Number : 8400019 | Flowood39232 | NCT06637631 | Map |
| NV | Vector Clinical Trials- Site Number : 8400001 | Las Vegas89128 | NCT06637631 | Map |
| NY | Icahn School of Medicine at Mount Sinai- Site Number : 8400001 | New York10029 | NCT06867094 | Map |
| NY | Queens Village Primary Medical Center- Site Number : 8400005 | Queens Village11428 | NCT06637631 | Map |
| NY | Queens Village Primary Medical Center- Site Number : 8400011 | Queens Village11428 | NCT06867094 | Map |
| NC | Carolina Digestive Diseases and Endoscopy Center- Site Number : 8400014 | Greenville27834 | NCT06637631 | Map |
| OH | NexGen Research- Site Number : 8400020 | Lima45805 | NCT06867094 | Map |
| PA | Frontier Clinical Research - Uniontown- Site Number : 8400006 | Uniontown15401 | NCT06867094 | Map |
| PA | Frontier Clinical Research - Uniontown- Site Number : 8400009 | Uniontown15401 | NCT06637631 | Map |
| SC | Medical University Of South Carolina - MUSC Health Ashley River Tower - ART- Site Number : 8400008 | Charleston29401 | NCT06867094 | Map |
| SC | Medical University Of South Carolina - MUSC Health Ashley River Tower - ART- Site Number : 8400016 | Charleston29401 | NCT06637631 | Map |
| TX | Gastro Health & Nutrition- Site Number : 8400003 | Katy77494 | NCT06637631 | Map |
| TX | Gastro Health & Nutrition- Site Number : 8400007 | Katy77494 | NCT06867094 | Map |
| TX | SI Research Associates- Site Number : 8400019 | Lubbock79424 | NCT06867094 | Map |
| TX | Texas Digestive Disease Consultants - Southlake- Site Number : 8400002 | Southlake76092 | NCT06637631 | Map |
| TX | Texas Digestive Disease Consultants - Southlake- Site Number : 8400015 | Southlake76092 | NCT06867094 | Map |
| WA | University of Washington Medical Center- Site Number : 8400014 | Seattle98195 | NCT06867094 | Map |
| WA | Washington Gastroenterology - Tacoma- Site Number : 8400008 | Tacoma98405 | NCT06637631 | Map |
| WA | Washington Gastroenterology - Tacoma- Site Number : 8400009 | Tacoma98405 | NCT06867094 | Map |
SAR441566 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | Total |
|---|---|---|---|
| P1 | 3 | 3 | |
| P2 | 2 | 2 | 4 |
Recruiting SAR441566 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06637631 | SPECIFI-CDA Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. | P2 | Crohn's Disease | 260 | Dec 2024 |
| NCT06867094 | SPECIFI-UCA Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis | P2 | Colitis Ulcerative | 204 | Mar 2025 |
SAR441566 clinical trials by indication
Rheumatoid Arthritis (3)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06073093 | SPECIFI-RA | P2 | completed | A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis |
| NCT05844735 | — | P1 | completed | A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 |
| NCT05858788 | — | P1 | completed | A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants. |
Psoriasis (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06073119 | SPECIFI-PSO | P2 | completed | A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis |
| NCT05453942 | — | P1 | completed | A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis |
Colitis Ulcerative (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06867094 | SPECIFI-UC | P2 | recruiting | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis |
Crohn's Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06637631 | SPECIFI-CD | P2 | recruiting | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. |
SAR441566 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| SPECIFI-CD | NCT06637631 | P2 | recruiting | Crohn's Disease | 260 | — |
| SPECIFI-UC | NCT06867094 | P2 | recruiting | Colitis Ulcerative | 204 | — |
| SPECIFI-RA | NCT06073093 | P2 | completed | Rheumatoid Arthritis | 264 | — |
| SPECIFI-PSO | NCT06073119 | P2 | completed | Psoriasis | 221 | — |
All SAR441566 trials (7)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06637631 | SPECIFI-CD | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. | P2 | recruiting | 260 | Sanofi | Dec 2024 |
| NCT06867094 | SPECIFI-UC | A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis | P2 | recruiting | 204 | Sanofi | Mar 2025 |
| NCT06073093 | SPECIFI-RA | A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis | P2 | completed | 264 | Sanofi | Nov 2023 |
| NCT06073119 | SPECIFI-PSO | A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis | P2 | completed | 221 | Sanofi | Oct 2023 |
| NCT05844735 | A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 | P1 | completed | 60 | Sanofi | May 2023 | |
| NCT05858788 | A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants. | P1 | completed | 10 | Sanofi | May 2023 | |
| NCT05453942 | A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis | P1 | completed | 38 | Sanofi | Jul 2022 |
SAR441566 clinical trials: frequently asked questions
- How many SAR441566 clinical trials are there?
- 7 SAR441566 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 5 are marked completed.
- Are SAR441566 clinical trials recruiting in 2026?
- Yes — 2 SAR441566 trials are actively recruiting in 2026, with 38 U.S. sites across 14 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is SAR441566 being studied for?
- SAR441566 is being studied for Rheumatoid Arthritis, Psoriasis, Colitis Ulcerative, Crohn's Disease. The trials are grouped by indication on this page.
- What phase is SAR441566 in?
- SAR441566 clinical trials span 4 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors SAR441566 clinical trials?
- The lead sponsor across the most SAR441566 trials is Sanofi. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming SAR441566as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: